As the end of the Transition Period on 31st December 2020 draws ever closer, pharmaceutical companies are preparing for life outside the EU Single Market and Customs Union. Holding additional stock could provide a buffer against any potential border disruption that could occur during the transition to the controls that…

With over 50 years’ combined experience across the Mawdsleys group, our dedicated MPW team have a vast understanding of the healthcare supply chain with background in the pre-wholesale, logistics, regulatory and clinical trials areas of the business. We are able to provide a flexible and highly reliable solution along with…